Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 151,856 | 8,152 | 4,590 | 3,825 | 460 |
| Cost of Goods | 3,945 | 811 | 1,950 | 2,043 | 4 |
| Gross Profit | 147,911 | 7,341 | 2,640 | 1,782 | 456 |
| Operating Expenses | 123,521 | 104,929 | 77,595 | 36,567 | 22,128 |
| Operating Income | 25,335 | -96,777 | -74,005 | -34,742 | -21,668 |
| Interest Expense | 4,980 | 1,610 | 1,652 | 1,629 | 253 |
| Other Income | -5,040 | 33,554 | 61,897 | 12 | 10 |
| Pre-tax Income | 15,315 | -64,833 | -13,760 | -36,359 | -21,911 |
| Income Tax | -36,038 | -896 | 36,314 | -1,702 | N/A |
| Net Income Continuous | 11,109 | -63,937 | -50,074 | -34,657 | -21,911 |
| Minority Interests | 1,977 | -3,014 | -4,263 | N/A | N/A |
| Net Income | $9,132 | $-60,923 | $-45,811 | $-34,657 | $-21,911 |
| EPS Basic Total Ops | 0.13 | -1.21 | -1.24 | -1.30 | -1.46 |
| EPS Basic Continuous Ops | 0.16 | -1.27 | -1.36 | -1.30 | -1.46 |
| EPS Diluted Total Ops | 0.13 | -1.21 | -1.24 | -1.30 | -1.46 |
| EPS Diluted Continuous Ops | 0.16 | -1.27 | -1.36 | -1.30 | -1.46 |
| EPS Diluted Before Non-Recurring Items | 0.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $32,473 | $-93,892 | $-71,635 | $-31,558 | $-20,378 |